# Cancer therapy using antiparasitic medications guided by acupuncture meridian assessment: a case series of six patients

Source: https://onco.cc/key-papers/paper-guilford-antiparasitic-acupuncture-meridian-case-series-2026/  
OnCo record `paper-guilford-antiparasitic-acupuncture-meridian-case-series-2026` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Six patients with advanced cancers treated over a decade with antiparasitic drugs chosen by measuring electrical conductance at acupuncture points were reported to have lived longer than expected; the method has no established basis and the series has no controls.

## Summary

Six patients with stage IV breast, lung, prostate, glioblastoma and multiple myeloma seen between 2011 and 2022 received combinations of ivermectin, mebendazole, praziquantel, niclosamide and antifungals selected by acupuncture meridian assessment, a modification of electroacupuncture according to Voll that measures skin conductance, with dental infections treated at the same time (Guilford case series 2026). The authors report survival beyond conventional expectation in all six and no serious adverse events, and call for further study (Guilford case series 2026).

## Fields

- Kind: Key paper
- Last checked: 2026-09-24
- Journal: Integrative Medicine (Encinitas)
- Year: 2026
- Authors: Guilford FT, Yu S.
- Findings: Six selected patients over eleven years; drug choice by skin-conductance readings; no controls.
- What it means: A case series selected by its authors from a decade of practice cannot show that any drug worked, and the selection method has no scientific basis.
- Caveats: Retrospective, uncontrolled, author-selected; several patients also had conventional treatment.; Acupuncture meridian assessment has no validated relation to drug choice.

## Sources

- Guilford case series 2026: https://pmc.ncbi.nlm.nih.gov/articles/PMC13377776/
- PubMed: https://pubmed.ncbi.nlm.nih.gov/42491797/

## Connected records

- technologies: [Fenbendazole, ivermectin and other internet 'repurposed cures'](https://onco.cc/technologies/fenbendazole-ivermectin-repurposing-claims/)
- drugs: [Ivermectin](https://onco.cc/drugs/ivermectin/), [Mebendazole](https://onco.cc/drugs/mebendazole/)
- bottlenecks: [Misinformation and unproven therapies](https://onco.cc/bottlenecks/b-misinformation/)

---
JSON: https://onco.cc/api/v1/entities/paper-guilford-antiparasitic-acupuncture-meridian-case-series-2026.json